Factor Xa or thrombin: is factor Xa a better target?

This publication has 38 references indexed in Scilit:

• STUDIES ON THE HEMORRHAGIC SWEET CLOVER DISEASE IV. THE ISOLATION AND CRYSTALLIZATION OF THE HEMORRHAGIC AGENT
  Nutrition Reviews, 2009
• Rivaroxaban for thromboprophylaxis after orthopaedic surgery: Pooled analysis of two studies
  Thrombosis and Haemostasis, 2007
• The effect of different anticoagulants on thrombin generation
  Blood Coagulation & Fibrinolysis, 2006
• Synthetic selective inhibitors of coagulation factor Xa strongly inhibit thrombin generation without affecting initial thrombin forming time necessary for platelet activation in hemostasis
  Journal of Thrombosis and Haemostasis, 2004
• Pharmacodynamic and Pharmacokinetic Properties of Enoxaparin
  Clinical Pharmacokinetics, 2003
• The Haemorrhagic Effect of Low Molecular Weight Heparins, Dermatan Sulphate and Hirudin
  Pathophysiology of Haemostasis and Thrombosis, 1995
• Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
  Journal of Clinical Investigation, 1990
• Theory and Practice of Minidose Heparin in Surgical Patients
  Circulation, 1973
• LOW DOSES OF HEPARIN IN PREVENTION OF DEEP-VEIN THROMBOSIS
  The Lancet, 1971
• An Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical Amplifier
  Nature, 1964